Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:998703rdf:typepubmed:Citationlld:pubmed
pubmed-article:998703lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:998703lifeskim:mentionsumls-concept:C0234708lld:lifeskim
pubmed-article:998703lifeskim:mentionsumls-concept:C0019744lld:lifeskim
pubmed-article:998703lifeskim:mentionsumls-concept:C0062815lld:lifeskim
pubmed-article:998703lifeskim:mentionsumls-concept:C0220901lld:lifeskim
pubmed-article:998703lifeskim:mentionsumls-concept:C1522609lld:lifeskim
pubmed-article:998703lifeskim:mentionsumls-concept:C1554112lld:lifeskim
pubmed-article:998703pubmed:issue6lld:pubmed
pubmed-article:998703pubmed:dateCreated1977-1-29lld:pubmed
pubmed-article:998703pubmed:abstractTextThe presence of the histocompatibility antigens HLA-B12 or HLA-B7 in 76 patients with increased intraocular pressure and a GG response to topical corticosteroids (intraocular pressure over 31 mm Hg after six weeks of topical 0.1% dexamethasone eyedrops, four times daily) correlated with the development of glaucomatous visual field loss. In close agreement with prevalences in patients with primary open-angle glaucoma, 14 (88%) of the 16 patients with increased intraocular pressure and a GG response who developed glaucomatous visual field loss had either HLA-B12 or B7 antigens. Fourteen (41%) of 34 patients with increased intraocular pressure and a GG response who had B12 or B7 antigens developed glaucomatous visual field loss but only two (5%) of 42 similar patients without either antigen had visual field loss. Other factors such as the initial intraocular pressure, the horizontal cup/disk ratio, and family history of glaucoma proved less valuable as prognostic indicators in this series.lld:pubmed
pubmed-article:998703pubmed:languageenglld:pubmed
pubmed-article:998703pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:998703pubmed:citationSubsetAIMlld:pubmed
pubmed-article:998703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:998703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:998703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:998703pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:998703pubmed:statusMEDLINElld:pubmed
pubmed-article:998703pubmed:monthDeclld:pubmed
pubmed-article:998703pubmed:issn0002-9394lld:pubmed
pubmed-article:998703pubmed:authorpubmed-author:BeckerBBlld:pubmed
pubmed-article:998703pubmed:authorpubmed-author:ShinD HDHlld:pubmed
pubmed-article:998703pubmed:issnTypePrintlld:pubmed
pubmed-article:998703pubmed:volume82lld:pubmed
pubmed-article:998703pubmed:ownerNLMlld:pubmed
pubmed-article:998703pubmed:authorsCompleteYlld:pubmed
pubmed-article:998703pubmed:pagination871-4lld:pubmed
pubmed-article:998703pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:998703pubmed:meshHeadingpubmed-meshheading:998703-H...lld:pubmed
pubmed-article:998703pubmed:meshHeadingpubmed-meshheading:998703-G...lld:pubmed
pubmed-article:998703pubmed:meshHeadingpubmed-meshheading:998703-P...lld:pubmed
pubmed-article:998703pubmed:meshHeadingpubmed-meshheading:998703-A...lld:pubmed
pubmed-article:998703pubmed:meshHeadingpubmed-meshheading:998703-D...lld:pubmed
pubmed-article:998703pubmed:meshHeadingpubmed-meshheading:998703-H...lld:pubmed
pubmed-article:998703pubmed:meshHeadingpubmed-meshheading:998703-H...lld:pubmed
pubmed-article:998703pubmed:year1976lld:pubmed
pubmed-article:998703pubmed:articleTitleThe prognostic value of HLA-B12 and HLA-B7 antigens in patients with increased intraocular pressure.lld:pubmed
pubmed-article:998703pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:998703pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:998703lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:998703lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:998703lld:pubmed